NEWS
Dayton Daily News | Biotech firm Axogen pushes $50 million Vandalia investment

A Florida biotechnology company pursuing what leaders believe is a revolutionary advancement in human tissue and nerve repair is investing some $50 million into its Dayton-area operations. Today, Florida-based Axogen has perhaps 65 employees at its Industrial Park Drive Vandalia location and in downtown Dayton. That number will soon rise, Peter Mariani, executive vice president […]

THE SCB PODCAST | What’s Wrong With the Biopharma Supply Chain?

Despite its success in rushing COVID-19 vaccines to market, the biopharmaceutical supply chain is far from perfect. Biopharma has played a starring role during the COVID-19 pandemic, developing and distributing vaccines in record time. Still, the industry is way behind the curve in adopting new technologies that will make its supply chain more efficient and […]

BioSpace | New CDC Guidelines and Tonix Pharma Focus on COVID-19 Long Haulers

Long COVID, or long-haulers syndrome, is a puzzling range of lingering symptoms and complications after COVID-19 infection. Last week, the U.S. Centers for Disease Control and Prevention (CDC) issued new guidance for long COVID, loosely defined as illness at least four weeks after acute infection. The guidance notes that primary care physicians can typically handle post-COVID conditions, but […]